You are here: Industry Insights > ATMP

News List

Coriolis Pharma and U-Medico Announce a Strategic Alliance b3cnewswire
March 17, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation...
Coriolis Pharma expands facilities for ATMP development cphi-online
June 24, 2021
The expansion close to company's Martinsried headquarters includes a lyophilisation development centre for advanced therapy medicinal products
Coriolis Pharma Expands ATMP Development Facilities contractpharma
June 22, 2021
Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety level S2 (BSL2 / S2).
Coriolis Pharma Expands its ATMP Development Facilities b3cnewswire
June 22, 2021
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, today announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2 / S2)
Yposkesi to Build Second Commercial Bioproduction Site contractpharma
June 15, 2021
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.
Cell and gene therapy: the impact of skills gaps in a fast-growing sector pharmaceutical-technology
April 15, 2021
Cell and gene therapy (CGT) is an experimental space that has grown exponentially in recent years; the sector received nearly $20bn in funding last year, a 50% increase on the record $13.5bn it saw in 2018.
Celonic to Boost Cell & Gene Therapy Production contractpharma
March 08, 2021
Celonic Group, a global contract development and manufacturing organization (CDMO) specialized in development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, has entered a long-term lease agreement for a new ...
UK sees a 20% growth in the number of advanced therapy trials, report finds pharmatimes
February 24, 2021
The UK has had a 20% growth in the number of advanced therapy medicinal product (ATMP) clinical trials, according to a new report from the Cell and Gene Therapy Catapult (CGT Catapult).
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal contractpharma
January 20, 2021
Bone Therapeutics, a cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Rigenerand SRL, a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for ...
Leukocare Starts Operations in the US contractpharma
January 12, 2021
Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, has opened its development laboratories and offices in Milford, MA.

Previous page 1 2 Next page